Year 2017 2018E 2019E 2020E: Patanjali Ayurved in Crs

Download as xlsx, pdf, or txt
Download as xlsx, pdf, or txt
You are on page 1of 2

PATANJALI AYURVED In Crs

0 1 2 3
Year 2017 2018E 2019E 2020E
Revenue 10000.00 15000.00 22500.00 33750.00
EBITDA 2000.00 3000.00 4500.00 6750.00
D&A <b> 80.00 120.00 180.00 270.00
EBIT 1920.00 2880.00 4320.00 6480.00
EBIT*(1-tax) <a> 1344.00 2016.00 3024.00 4536.00
Capex <c> 200.00 300.00 450.00 675.00
FCF to company (a+b-c) 1836.00 2754.00 4131.00
Terminal value (2023 onwards)
FCF + Terminal value 1836.00 2754.00 4131.00
Enterprise Value <d> ₹59,937.96
4 5 Assumptions
2021E 2022E Discount Rate 12%
50625.00 75937.50 Tax rate 30%
10125.00 15187.50 Revenue Growth 50%
405.00 607.50 EBITDA Margin 20%
9720.00 14580.00 D&A (% of Capex) 40%
6804.00 10206.00 Capex (% of Revenue) 2%
1012.50 1518.75
6196.50 9294.75
77456.25
6196.50 86751.00

You might also like

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy